GlassScriptPhysician profile
Robert W Schriner
NPI 1891791349
$11,869.20
in general payments reported to CMS, 2019-2025
47 companies · $3,358 in 2025
The $3,358 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $785 · 2020: $292 · 2021: $424 · 2022: $2,248 · 2023: $2,499 · 2024: $2,263 · 2025: $3,358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,874 · Education: $247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,873.77 |
| Education | $246.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $1,757.10 | 2020-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $1,538.09 | 2019-2025 | Xywav |
| Astrazeneca Pharmaceuticals LP | $1,328.05 | 2019-2025 | Breztri, Airsupra, Fasenra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $812.10 | 2022-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Genzyme Corporation | $541.00 | 2019-2025 | |
| Glaxosmithkline, LLC. | $464.72 | 2022-2025 | Trelegy Ellipta, Nucala |
| Inspire Medical Systems, INC. | $461.62 | 2019-2025 | Inspire |
| Avadel Cns Pharmaceuticals, LLC | $382.13 | 2023-2025 | Lumryz |
| Insmed, INC. | $377.11 | 2020-2025 | Arikayce, Brinsupri |
| La Jolla Pharmaceutical Company | $339.90 | 2019-2023 | Giapreza |
| Merck Sharp & Dohme LLC | $308.31 | 2023-2025 | Zerbaxa, Recarbrio, Keytruda |
| Takeda Pharmaceuticals U.S.A., INC. | $302.96 | 2022-2025 | Glassia |
| Genentech USA, INC. | $273.28 | 2022-2023 | Xolair |
| Regeneron Healthcare Solutions, INC. | $261.94 | 2022-2025 | Dupixent |
| United Therapeutics Corporation | $255.59 | 2022-2025 | Tyvaso, Tyvaso |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $242.63 | 2025 | Zepbound |
| Mylan Specialty L.P. | $214.82 | 2022-2024 | Yupelri |
| Mallinckrodt Hospital Products INC. | $206.71 | 2022-2024 | Acthar |
| Actelion Pharmaceuticals US, INC. | $172.15 | 2023-2025 | Uptravi, Opsumit, Opsynvi |
| Verona Pharma, INC. | $148.40 | 2025 | Ohtuvayre |
| Philips North America LLC | $127.13 | 2019-2025 | Reusable Vest, Vest Therapy Und |
| Gilead Sciences, INC. | $126.84 | 2021-2023 | |
| Eisai INC. | $125.00 | 2019 | |
| Axsome Therapeutics, INC. | $119.30 | 2023-2025 | Sunosi |
| Amgen INC. | $101.12 | 2022-2025 | Tezspire |
| Abbvie INC. | $91.51 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $90.29 | 2022-2024 | |
| Fisher & Paykel Healthcare INC | $87.18 | 2019-2023 | Fisher & Paykel Healthcare |
| Alexion Pharmaceuticals, INC. | $77.90 | 2022 | |
| Novartis Pharmaceuticals Corporation | $66.90 | 2022-2024 | |
| Edwards Lifesciences Corporation | $61.77 | 2023-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Ani Pharmaceuticals, INC. | $51.01 | 2024 | Purified Cortrophin Gel |
| Viatris Specialty LLC | $48.79 | 2025 | Yupelri |
| Baxter Healthcare | $46.52 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Pfizer INC. | $37.13 | 2022 | |
| Pinnacle Biologics, INC | $25.89 | 2024 | Photofrin |
| Shionogi INC | $24.30 | 2023 | Fetroja |
| Ambu INC. | $24.09 | 2022 | |
| Davol INC. | $23.85 | 2023 | |
| Grifols USA, LLC | $20.54 | 2023 | Prolastin-C Liquid |
| Liquidia Technologies, INC. | $17.93 | 2025 | Yutrepia |
| Azurity Pharmaceuticals, INC. | $16.50 | 2023 | Horizant |
| Advanced Respiratory, INC | $15.10 | 2020 | |
| Mayne Pharma Commercial LLC | $14.81 | 2019 | |
| Vapotherm INC | $14.43 | 2022 | |
| 3b Medical, INC. | $12.48 | 2023 | Luna |
| Inogen, INC. | $12.28 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Schriner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.